Abstract
Marek's disease virus latent protein MEQ (MDV Eco Q) is abundantly expressed and consistently detected in MDV-induced tumors and cell lines. Deletion mutants were constructed to study the domain structure of MEQ. Four deletion mutants were obtained in the basic regions of MEQ, namely basic region 1 (ΔBR1), basic region 2 (ΔBR2), basic regions 1 and 2 (ΔBR1 and 2), and the C-terminal (bZIP) domain. The BR1 and BR2 are nuclear localization signals and either is sufficient to cause transport of MEQ into the nucleus. In addition, the BR2 is also responsible for MEQ's nucleolar localization. A monoclonal antibody (Mab 23B46) was produced using recombinant fowlpox virus (rFPV) expressing MEQ (rFPV/MEQ) as a source of protein. The isotype of Mab 23B46 is IgG1 and immunoprecipitated a band in rFPV/MEQ infected cells with molecular weight of 60 kDa specific to MEQ protein. We detected abundant expression of MEQ in (rFPV/MEQ), recombinant baculovirus (rBac) (rBac/MEQ), and lymphoid tumors induced by MDV. In order to delineate the epitope of MEQ reactive with Mab 23B46, we used four deletion mutants from the basic and bZIP domains. We found the deletions in the N-terminal region including BR1 (ΔBR1), and (ΔBR1 and 2) completely abolished the specific binding with Mab 23B46 as shown by Western blot analysis and immunofluoresence test. Deletion of BR2 (ΔBR2) and the C-terminal (bZIP) domain had no effect on antibody binding. These data provide direct evidence that monoclonal antibody reactive epitope is localized in the BR1 domain of the molecule. Since both BR1 and BR2 domains contain sequences important for nuclear entry, we now have reagent to further study and elucidate the mechanism of MEQ's involvement in nuclear and nucleolar localization.
Similar content being viewed by others
References
Calnek B.W. and Witter R.L., in Calnek B.W., Barnes H.J., Beard C.W., McDougald L.R., and Saif Y.M. (eds), Diseases of Poultry, Iowa State University Press, Ames, 1997, pp. 369-413.
Nazerian K., Solomon J.J., Witter R.L., and Burmester B.R., Studies on the etiology of Marek's disease. II. Finding of a herpesvirus in cell culture. Proc Soc Exp Biol & Med 127, 177-182, 1968.
Chubb R.C. and Churchill A.E., Precipitating antibodies associated with Marek's disease. Vet Rec 82, 4-7, 1968.
Lee L.F., Liu X., and Witter R.L., Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J Immunol 130, 1003-1006, 1983.
Schat K.A. and Calnek B.W., Characterization of an apparently nononcogenic Marek's disease virus. J Natl Cancer Inst 60, 1075-1082, 1978.
Witter R.L., Nazerian K., Purchase H.G., and Burgoyne G.H., Isolation from turkeys of a cell associated herpesvirus antigenically related to Marek's disease virus. Amer J Vet Res 31, 525-538, 1970.
Afonso C.L., Tulman E.R., Lu Z., Zsak L., Rock D.L., and Kutish G.F., The genome of turkey herpesvirus. J Virol 75, 971-978, 2001.
Izumiya Y., Jang H.K., Ono M., and Mikami T., A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Curr Top Microbiol Immunol 255, 191-221, 2001.
Lee L.F., Wu P., Sui D., Ren D., Kamil J., Kung H.J., and Witter R.L., The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc Natl Acad Sci USA 97, 6091-6096, 2000.
Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., and Kutish G.F., The genome of a very virulent Marek's disease virus. J Virol 47, 7980-7988, 2000.
Tillotson J.K., Lee L.F., and Kung H.J., Accumulation of viral transcripts coding for a DNA binding protein in Marek's disease tumor cells. in Kato S., Horiuchi T., Mikami T., and Hirai K., Advances in Marek's Disease Research. 3rd International Marek's Disease Symposium Proceedings Osaka, Japan, 1988, pp. 128-134.
Jones D., Lee L.F., Liu J.L., Kung H.J., and Tillotson J.K., Marek's disease virus encodes a basic leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci 89, 4042-4046, 1992.
Qian Z., Brunovskis P., Rauscher III F., Lee L.F., and Kung H.J., The transactivation activity of meq, a Marek's disease herpes virus b-ZIP protein persistently expressed in latently-infected transformed T-cells. J Viral 69, 4037-4044, 1995.
Qian Z., Brunovskis P., Lee L.F., Vogt P.K., and Kung H.J., Novel-binding specificities of a putative herpesvirus bZIP oncoprotein. J Viral 70, 7161-7170, 1996.
Peng Q., Zeng M., Bhuiyan Z.A., Ubukata E., Tanaka A., Nonoyama M., and Shirazi Y., Isolation and characterization of MDV cDNAs mapping to the BamH1-12, Q2, L-fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213, 590-599, 1995.
Gimeno I.M., Witter R.L., Hunt H.D., Lee L.F., Reddy S.M., and Neumann U., Marek's disease virus infection in the brain: Virus replication, cellular infiltration, and major histocompatibility complex antigen expression. Vet Pathol 38, 491-503, 2001.
Ross N., O'Sullivan G., Rothwell C., Smith G., Rennie M., Lee L.F., and Davison T.F., Marek's disease virus EcoRI-Q gene (Meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas. J Gen Virol 78, 2191-2198, 1997.
Liu J.L., Lee L.F., Ye Y., Qian Z., and Kung H.J., Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. J Virol 71, 3188-3196, 1997.
Cui X., Wei P., Lee L.F., Holland M., Silva R., and Kung H.J., Characterization of the expression of the Marek's disease virus MEQ gene in a recombinant baculovirus, in Schat K.A., Morgan R.M., Parcells M.S., and Spencer J.L. (eds), Current Progress on Marek's Disease Research, 2001, pp. 135-139.
Nazerian K., Lee L.F., Yanagida N., and Ogawa R., Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J Virol 69, 1409-1413, 1992.
Yanagida N., Ogawa R., Li Y., Lee L.F., and Nazerian K., Recombinant fowlpox viruses expressing the glycoprotein B and the pp38 genes of Marek's disease virus. J Virol 66, 1402-1408, 1992.
Silva R.F. and Lee L.F., Monoclonal antibody-mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpesvirus. Virology 136, 307-320, 1984.
Liu J.L., Ye Y., Lee L.F., and Kung H.J., Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis. J Virol 72, 388-395, 1998.
Xie Q., Anderson A.S., and Morgan R.W., Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB-1 MDV-transformed lymphoblastoid cells. J Virol 70, 1125-1131, 1996.
Silva R.F., Lupiani B., and Reddy S.M., The effect of deleting or inverting the 132 base pair repeats in a pathogenic MDV. In Workshop on Molecular Pathogenesis of Marek's Disease and Avian Immunology. 2002. Limassol, Cyprus: BARD.
Cui X.-P., Lee L.F., Gimeno I., Reed W.M., and Reddy S.M., Mutagenesis and in vivo studies of Marek's disease virus encoded interleukin 8 like gene (vIL8), AVMA Convention Notes. 2002.
Kent J., Anderson A., and Morgan R., Marek's disease virus gC and meq mutants with dramatic reductions in tumor incidences and horizontal transmission. In: International Herpesvirus Workshop: 532, 1997.
Parcells M.S., Lin S.F., Dienglewicz R.L., Majerciak V., Robinson D.R., Chen C.H., Wu Z., Dubyak G.R., Brunovskis P., Hunt H.D., Lee L.F., and Kung H.J., Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL8): Characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75, 5159-5173, 2001.
Reddy S.M., Lupiani B., Gimeno I.M., Silva R.F., Lee L.F., and Witter R.L., Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: Use of a pp38 mutant to validate the technology for the study of gene function. Proc Natl Acad Sci USA 99, 7054-7059, 2002.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, L.F., Liu, JL., Cui, XP. et al. Marek's Disease Virus Latent Protein MEQ: Delineation of an Epitope in the BR1 Domain Involved in Nuclear Localization. Virus Genes 27, 211–218 (2003). https://doi.org/10.1023/A:1026334130092
Issue Date:
DOI: https://doi.org/10.1023/A:1026334130092